Navigation Links
Confronting the challenge of antimicrobial resistance
Date:3/10/2008

Drug resistance is making many diseases increasingly difficult--and sometimes impossible--to treat, according to Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Extensively drug-resistant tuberculosis and invasive methicillin-resistant Staphylococcus aureus (MRSA) infections are just two recent examples of this problem that pose serious threats to domestic and global health, he adds. In a new report in the Journal of Infectious Diseases, now available online, Dr. Fauci outlines NIAIDs commitment to addressing this urgent public health issue.

The innate ability of microbes to evade containment and destruction by drugs through rapid reproduction and genetic mutation is exacerbated by the overuse and misuse of existing antimicrobial drugs, Dr. Fauci and his coauthors note. Other factors contributing to the upswing in drug resistance include a dearth of rapid diagnostic tests that would allow physicians to better gauge whether a given infection is drug-susceptible or drug-resistant, and a paucity of clinical trial data to guide therapeutic strategies.

NIAID is meeting the complex challenge of antimicrobial resistance through a multifaceted research approach that includes partnerships with other federal agencies, academia, industry and non-governmental organizations, the authors report. In fiscal year 2007, NIAID invested more than $800 million to support basic and translational research on antimicrobials, more than $200 million of which was devoted to understanding the causes, consequences and treatments of antimicrobial drug resistance.

Basic research projects under way at NIAID or in NIAID-supported labs across the country include the following:

  • Investigations of mechanisms of resistance and how these traits are acquired and passed on by microbes
  • Research on factors that contribute to the virulence of pa
    '/>"/>

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. ADA Challenges Marylanders to Step Out to Fight Diabetes Epidemic
2. LifeQuest Announces End of Immunity Health Challenge Contest
3. Braun Challenges Business School Talent To Create A Buzz
4. Medifast Announces Winners of Mother-Daughter Challenge
5. The Fight for His Life: Author, Family Battle Disease and Challenge Politics in the Face of Survival
6. Genetics Hold Promise, Challenges for Cancer Care
7. Actavis Confirms its Patent Challenge of Kings Avinza(R)
8. Childhood Obesity Epidemic a Long-Term Challenge
9. Planning for 2020: increasing elderly population poses huge challenges in cancer care
10. Barr Confirms Patent Challenge of UROXATRAL(R)
11. The Challenge: Make It A Million (Pounds Lost That Is)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... vitamin D begins in the womb, expert says, , , ... mothers who drink lots of milk and have a ... a much lower risk of developing multiple sclerosis later ... 35,794 U.S. nurses whose mothers provided information about their ... for 16 years, and 199 of them developed multiple ...
(Date:2/9/2010)... blood pressure restrict fetal growth, study finds, , , TUESDAY, ... bring into pregnancy can have lasting effects on your ... found that women who smoked, had high blood pressure ... babies that were smaller in the first trimester of ... , "Our study demonstrates that several maternal physical characteristics ...
(Date:2/9/2010)... Insurer-favored ,Cost Solution,: Selling Policies That Amount To ,A ... WASHINGTON , Feb. 9 Blue ... with its premium hikes of up to 39% in ... of questions from the White House and an investigation ... lawmakers should act to regulate health insurance premiums and ...
(Date:2/9/2010)... , Feb. 9 ... J. James Rohack , M.D., President, American ... ,, "The American Medical Association is ... Obama in the Let,s Move Campaign. ... have long worked to address obesity and ...
(Date:2/9/2010)... Institute and the Sanford-Burnham Medical Research Institute have ... owned member of the Roche group, and Roche, ... develop and market human monoclonal antibodies to treat ... viruses include the strains for the current seasonal ... a non-exclusive right to manufacture, develop and market ...
Breaking Medicine News(10 mins):Health News:Drinking Milk While Pregnant May Lower Kids' MS Risk 2Health News:Mom's Lifestyle in Early Pregnancy Affects Baby's Size 2Health News:Mom's Lifestyle in Early Pregnancy Affects Baby's Size 3Health News:Blue Cross Claim That 39% Premium Hikes Due Only to 'Escalating Cost of Health Care' Trigger Calls for Regulation of Rates 2Health News:Blue Cross Claim That 39% Premium Hikes Due Only to 'Escalating Cost of Health Care' Trigger Calls for Regulation of Rates 3
... of parents will be required by teenagers in Scotland who ... tattoo studios will also be subject to mandatory licensing// to ... to all those who are less than 16 years of ... the possibilities of blood borne diseases being transmitted through contaminated ...
... mother Bernadette Mimura, belonging to Ingleby Barwick Ingleby Barwick who ... disease//. She had refused life-saving treatment as it involved making ... the unborn baby, by the doctors. ,Being a ... a mild form of chemotherapy treatment with the object of ...
... to feel happy about the way he looks by just looking ... looks great he is convinced//. ,Women on the other ... difficult to satisfy them unless they are supplemented with actual results. ... was conducted by Kathleen Martin Ginis, associate professor of kinesiology at ...
... that moderate exercise has positive benefits on the hearts, ... studies in the last 10 to 20 years have ... people suffering from congestive heart failure. ,However, the ... to be statistically significant. ,In the new study ...
... on the Gulf of Carpentaria in Australia has triggered concerns ... virus//. ,However, the Australian Quarantine and Inspection Service ... they were sending out a team as a precautionary measure, ... a military operative has also started towards the island. "There's ...
... has been found to be effective in treatment of ... benefited from vitamin treatment as found by researchers from ... intervention wherein patients not responsive to steroid treatment after ... ,Professor Tak Lee, Director of the MRC-Asthma UK ...
Other Medicine News:Health News:Asthma an be treated with Vitamin supplement intervention 2
(Date:2/9/2010)... February 9 Debiopharm Group,(Debiopharm), ... with,a focus on the development of prescription ... the signature of an exclusive licence agreement ... of Debio 025,(alisporivir), a selective, first-in-class cyclophilin ... (HCV) effect. The product is currently in ...
(Date:2/8/2010)... FRANKLIN LAKES, N.J. , Feb. 8 /PRNewswire/ ... and Company), announced today the launch of BD Microtainer® ... new product is designed to improve the safety, accuracy ... in patients with veins that can be difficult to ... elderly. The new BD Microtainer MAP product is also ...
(Date:2/8/2010)... Sagent Pharmaceuticals, Inc., a privately held ... received FDA approval of labetalol hydrochloride (HCl) injection, ... product will be available in two vial sizes ... mg per 40 mL, multi-dose vials.  According to ... Americans have hypertension, or high blood pressure.  IMS ...
Breaking Medicine Technology:Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 2Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 3BD Launches New Device Designed to Improve Safety, Accuracy and Turnaround Time of Blood Collection in Patients with Fragile Veins 2Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP 2Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP 3New and Updated Online Tutorials for ArrayExpress Allen Brain Atlas and CleanEx from OpenHelix 54389 1New and Updated Online Tutorials for ArrayExpress Allen Brain Atlas and CleanEx from OpenHelix 54389 2New and Updated Online Tutorials for ArrayExpress Allen Brain Atlas and CleanEx from OpenHelix 54389 3Cancer Mortality Rates Experience Steady Decline 54386 1Cancer Mortality Rates Experience Steady Decline 54386 2Cancer Mortality Rates Experience Steady Decline 54386 3Cancer Mortality Rates Experience Steady Decline 54386 4APHL Chosen by PEPFAR to Develop Global Health Laboratory Systems 54384 1APHL Chosen by PEPFAR to Develop Global Health Laboratory Systems 54384 2
... May 31 Eli Lilly and Company announced today ... Lilly,s GEMZAR(R) (gemcitabine HCl for injection) to the current ... progression-free survival at three years for women with locally ... second most commonly diagnosed women,s cancer, and the second ...
... than double risk of cancer recurrence in tamoxifen treated ... drugs that reduce its effectiveness against breast cancerORLANDO, Fla., ... certain popular antidepressants frequently prescribed to women taking the ... of a breast cancer recurrence for those using both ...
Other Medicine Technology:Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 2Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 3Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 4Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 5Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 6New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 2New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 3New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 4New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 5
... Every Bard® Biopsy Instrument and Needle ... one important goal: a large quality, reliable ... exceptional performance, featuring ultra-sharp tips and polished ... broad selection of biopsy systems and needle ...
... Needle is specially designed to help you ... reliable core sample. All needles are engineered ... polished surfaces for smooth entry and exit. ... needle sizes assures an ideal match with ...
... designed to bring efficiency and quality to ... the superior technology of fluorescent flow cytometry ... Continuous sampling or batch processing are easily ... processing in high volume laboratories. Fluorescent ...
... Cartridge System is a single-use, disposable needle ... spacers into a Bard BrachyStar needle for ... outer radiation safety shield, inner compartment that ... molded fitting that connects the cartridge to ...
Medicine Products: